Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Short Ajanta Pharma, says Shrikant Chouhan, VP Technical Research of Kotak Securities.
On CNBC-TV18's in Super Six show, market gurus Hemen Kapadia, CEO of chartpundit.com, Shrikant Chouhan, VP Technical Research of Kotak Securities and Sanjeev Agarwal, CEO of Dynamix Research & Capital Management, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Buy Ajanta Pharma with a stoploss of Rs 325, says Rajesh Agarwal, Head of Research at Eastern Financiers.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Ajanta Pharma has target of Rs 320, says Rajesh Jain, Market Strategist
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest. Remember these are midcap ideas not just for the day, but stocks that look attractive in the medium-term as well.